Published in Lancet on March 28, 1964
Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol (1966) 18.33
Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol (1967) 8.29
Proteins specified by herpes simplex virus. 3. Viruses differing in their effects on the social behavior of infected cells specify different membrane glycoproteins. Proc Natl Acad Sci U S A (1970) 4.97
Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med (1976) 4.83
MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. J Exp Med (1965) 4.76
Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J Virol (1971) 4.09
Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J Virol (1976) 3.83
Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proc Natl Acad Sci U S A (1969) 3.72
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56
ISOLATION OF A REOVIRUS FROM A CASE OF BURKITT'S LYMPHOMA. Br Med J (1964) 3.17
Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A (1973) 3.14
DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness. J Virol (1975) 3.13
Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer (1976) 3.11
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain (2009) 3.04
Immunity to malignant disease in man. Br Med J (1969) 2.88
Large-volume purification of tumor viruses by use of zonal centrifuges. Appl Microbiol (1972) 2.74
Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J Virol (1980) 2.69
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med (1996) 2.67
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood (2008) 2.66
Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family. Proc Natl Acad Sci U S A (1986) 2.62
Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc Natl Acad Sci U S A (1983) 2.61
Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells. J Virol (1979) 2.61
Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. Br Med J (1968) 2.52
Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J Virol (1973) 2.44
Burkitt's tumour in the West Nile District Uganda, 1961-5. Br Med J (1967) 2.43
Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol (1990) 2.43
Epstein-barr virus-specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive, and prooductive infections. J Virol (1977) 2.38
Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis (2012) 2.33
A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. J Virol (1988) 2.27
Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev (2011) 2.22
An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci U S A (1988) 2.20
Isolation of a type C RNA virus from an established human histiocytic lymphoma cell line. Proc Natl Acad Sci U S A (1977) 2.18
Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. J Virol (1972) 2.17
Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias. J Bacteriol (1966) 2.10
DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci U S A (1973) 2.02
Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A (1989) 2.01
A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes. J Virol (1988) 1.99
Viral-related RNA in Hodgkins' disease and other human lymphomas. Proc Natl Acad Sci U S A (1972) 1.98
Malignant tumours following immunosuppressive therapy. Can Med Assoc J (1970) 1.97
The post-transplant lymphoproliferative disorder-a literature review. Pediatr Nephrol (2004) 1.92
Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1967) 1.91
Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev (1995) 1.90
Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. J Virol (1987) 1.87
Polypeptides of the Epstein-Barr virus membrane antigen complex. J Virol (1979) 1.86
Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol (2002) 1.82
Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev (1988) 1.78
THE BEHAVIOUR AND MORPHOLOGY OF A SECOND TISSUE CULTURE STRAIN (EB2) OF LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Br J Cancer (1965) 1.69
Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis. Proc Natl Acad Sci U S A (1974) 1.62
Identification of the Epstein-Barr virus gp85 gene. J Virol (1988) 1.61
Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci U S A (2011) 1.59
EVIDENCE FOR A PERSISTENT VIRAL INFECTION IN A CELL LINE DERIVED FROM BURKITT'S LYMPHOMA. J Bacteriol (1965) 1.58
Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol (1983) 1.57
Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol (1998) 1.55
"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev (1994) 1.54
Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion. J Virol (2004) 1.49
Viruses associated with human cancer. Biochim Biophys Acta (2007) 1.47
Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn (2001) 1.47
Breastfeeding and childhood cancer. Br J Cancer (2001) 1.45
Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci U S A (2005) 1.45
Burkitt's tumors contain particles encapsulating RNA-instructed DNA polymerase and high molecular weight virus-related RNA. Proc Natl Acad Sci U S A (1973) 1.44
Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines. J Virol (1981) 1.44
EB virus antibody at different ages. Br Med J (1969) 1.43
Replication of herpes-type virus in a Burkitt lymphoma cell line. J Virol (1967) 1.43
Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol (2000) 1.42
Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells. J Virol (1976) 1.41
Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man. Yale J Biol Med (1971) 1.38
Significance of the changes in the circulating lymphoid cells in Hodgkin's disease. Br Med J (1969) 1.35
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol (1993) 1.31
Neoplasms, differentiations and mutations. Am J Pathol (1974) 1.30
Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. J Virol (2011) 1.30
Infectious mononucleosis: detection of herpeslike virus and reticular aggregates of small cytoplasmic particles in continuous lymphoid cell lines derived from peripheral blood. Proc Natl Acad Sci U S A (1968) 1.28
Carcinogens in the nose and throat: nasopharyngeal carcinoma in Kenya. Proc R Soc Med (1972) 1.27
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res (2011) 1.25
Epstein-Barr virus infection and human malignancies. Int J Exp Pathol (2001) 1.24
100 years of Rous sarcoma virus. J Exp Med (2011) 1.24
RNA related to that of a murine leukemia virus in Burkitt's tumors and nasopharyngeal carcinomas. Proc Natl Acad Sci U S A (1973) 1.23
Serologic evidence that a herpes-type virus is the etiologic agent of heterophile-positive infectious mononucleosis. Proc Natl Acad Sci U S A (1971) 1.22
Electron microscopic localization of herpesvirus-type particles in Marek's disease. J Virol (1968) 1.22
On the stem cell origin of cancer. Am J Pathol (2010) 1.21
Rescue of transforming Epstein-Barr virus (EBV) from EBV-genome-positive epithelial hybrid cells transfected with subgenomic fragments of EBV DNA. Proc Natl Acad Sci U S A (1983) 1.20
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement. J Clin Invest (1982) 1.20
Signaling activities of gammaherpesvirus membrane proteins. J Virol (2000) 1.19
Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol (2012) 1.19
Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes. Br J Cancer (1982) 1.18
Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J Virol (2010) 1.17
Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. II. NZB mice. Clin Exp Immunol (1970) 1.17
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol (2009) 1.16
No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol (2001) 1.14
Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. J Clin Pathol (1992) 1.14
Further isolations of reovirus type 3 from cases of Burkitt's lymphoma. Br Med J (1966) 1.14
The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding. Proc Natl Acad Sci U S A (2002) 1.11
Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One (2013) 1.11
RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc Natl Acad Sci U S A (2014) 1.10
Functional analysis of glycoprotein L (gL) from rhesus lymphocryptovirus in Epstein-Barr virus-mediated cell fusion indicates a direct role of gL in gB-induced membrane fusion. J Virol (2009) 1.10
A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells. J Virol (2004) 1.10
Adoptive cellular immunotherapy for virus-associated cancers: a new paradigm in personalized medicine. Immunol Cell Biol (2017) 1.09
Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood (2011) 1.09
Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. BMC Genomics (2011) 1.09
MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. J Exp Med (1965) 4.76
CULTIVATION IN VITRO OF HUMAN LYMPHOBLASTS FROM BURKITT'S MALIGNANT LYMPHOMA. Lancet (1964) 3.95
A SECOND VIRUS-CARRYING TISSUE CULTURE STRAIN (EB2) OF LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Pathol Biol (Paris) (1964) 2.57
Observations on the mode of release of herpes virus from infected HeLa cells. J Cell Biol (1962) 2.29
Some unusual features of fine structure observed in HeLa cells. J Biophys Biochem Cytol (1961) 2.17
The fine structure of the cells in mouse sarcoma 37 ascitic fluids. J Biophys Biochem Cytol (1957) 2.17
CHARACTERISTICS AND MODE OF GROWTH OF TISSUE CULTURE STRAIN (EB1) OF HUMAN LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. J Natl Cancer Inst (1965) 2.01
Observations on the fine structure of mature herpes simplex virus and on the composition of its nucleoid. J Exp Med (1962) 1.91
An investigation into the purifying effect of a fluorocarbon on vaccinia virus. Br J Exp Pathol (1958) 1.82
Growth of Mycobacterium lepraemurium maintained in cultures of rat fibrolasts. J Gen Microbiol (1962) 1.79
FINE STRUCTURAL ORGANIZATION OF HUMAN LYMPHOBLASTS OF A TISSUE CULTURE STRAIN (EB1) FROM BURKIT'S LYMPHOMA. J Natl Cancer Inst (1965) 1.74
THE BEHAVIOUR AND MORPHOLOGY OF A SECOND TISSUE CULTURE STRAIN (EB2) OF LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Br J Cancer (1965) 1.69
THE ENTRY AND DISTRIBUTION OF HERPES VIRUS AND COLLOIDAL GOLD IN HELA CELLS AFTER CONTACT IN SUSPENSION. J Exp Med (1964) 1.67
LYMPHOBLASTIC LYMPHOMA IN BONE-MARROW OF AFRICAN GREEN MONKEYS (CERCOPITHECUS AETHIOPS) INOCULATED WITH BIOPSY MATERIAL FROM A CHILD WITH BURKITT'S LYMPHOMA. Lancet (1964) 1.67
Therapeutic factors in survival after lethal cholinesterase inhibition by phosphorus insecticides. N Engl J Med (1955) 1.59
The isolation of type 5 adenovirus using a fluorocarbon; combined morphological and biological studies. Br J Exp Pathol (1960) 1.51
The fine structural organisation of Rous tumour cells. J Biophys Biochem Cytol (1957) 1.48
THE LOCALIZATION BY ELECTRON MICROSCOPY OF HELA CELL SURFACE ENZYMES SPLITTING ADENOSINE TRIPHOSPHATE. J Cell Biol (1963) 1.39
Composition of the Rous virus nucleoid. Nature (1958) 1.34
The identification of the Rous virus; a morphological and biological study. Br J Cancer (1956) 1.33
Cytochemical and electron microscopical observations on substances associated with fluorocarbon purified vaccinia virus. Br J Exp Pathol (1958) 1.31
ELECTRON MICROSCOPE OBSERVATIONS ON THE SURFACE ADENOSINE TRIPHOSPHATASE-LIKE ENZYMES OF HELA CELLS INFECTED WITH HERPES VIRUS. J Cell Biol (1963) 1.21
Observations on the fine structure of type 5 adenovirus. J Biophys Biochem Cytol (1959) 1.21
Structural differentiation in the nucleoid of mature vaccinia virus. Nature (1958) 1.17
The fine structure and composition of type 5 adenovirus; an integrated electron microscopical and cytochemical study. Br J Exp Pathol (1960) 1.10
Observations on the Rous virus; integrated electron microscopical and cytochemical studies of flucrocarbon purified preparations. Br J Cancer (1958) 1.10
Nucleic acid of mature herpes simplex virus: its type and location. Nature (1962) 1.04
Studies on a group of oximes as therapeutic compounds in sarin poisoning. J Pharmacol Exp Ther (1957) 1.02
Toxicity of hydroxamic acid analogues; prophylactic and therapeutic efficacy against nerve gas poisoning in mice. Proc Soc Exp Biol Med (1957) 1.01
Observations on the Rous virus; purification and identification of the particles from solid tumours. Br J Cancer (1958) 0.96
Ventricular standstill during the intravenous procaine amide treatment of ventricular tachycardia. Am Heart J (1953) 0.96
The effects of microwaves on the Rous No. 1 fowl sarcoma virus. Br J Cancer (1951) 0.96
The electron microscopy of tissue cells; a brief review including reference to virus-infected cells. Arch Middx Hosp (1955) 0.94
A simple technique for the electron microscopy of fresh ascites tumour cells. Exp Cell Res (1955) 0.91
Site and nature of adenovirus nucleic acid. Nature (1960) 0.90
Acute bacterial endocarditis following mitral valvuloplasty. Am Heart J (1955) 0.89
A diamond knife holder for microtomes designed to take glass knives. J Biophys Biochem Cytol (1958) 0.89
Functional aspects of the structure of some animal viruses. Br Med Bull (1962) 0.85
CYTOCHEMICAL AND ELECTRON MICROSCOPICAL OBSERVATIONS ON THE PRESENCE AND ORIGIN OF ADENOSINE TRIPHOSPHATASE-LIKE ACTIVITY AT THE SURFACE OF TWO MYXOVIRUSES. J Bacteriol (1965) 0.85
Observations on the Rous virus; fine structure and relation to cytoplasmic vacuoles. Br J Cancer (1957) 0.84
A technique for transferring cells prepared on Formvar coated slides to electron microscope specimen grids. J R Microsc Soc (1956) 0.82
Multiplication of rat-leprosy bacilli in cultures of rat fibroblasts. Lancet (1958) 0.81
Constitution of tumor viruses. Natl Cancer Inst Monogr (1960) 0.81
A METHOD FOR PREPARING MICROSAMPLES OF SUSPENDED CELLS FOR LIGHT AND ELECTRON MICROSCOPY. J R Microsc Soc (1965) 0.80
Analysis of H wave of ballistocardiogram. Circulation (1950) 0.76
The effects of cold and desiccation on the tumour-producing activity of the cells and the virus of the Rous no. 1 fowl sarcoma. Br J Cancer (1951) 0.75
The electron microscopy of viruses. Proc R Soc Med (1961) 0.75
ADDICTION OF PETROL VAPOUR. Lancet (1964) 0.75
NAUSEA AS THE CHIEF COMPLAINT IN THYROTOXICOSIS. Calif Med (1965) 0.75
DESFERRIOXAMINE AND IRON. Lancet (1964) 0.75
The effect on the Rous No. 1 fowl sarcoma virus of Berkefeld filtration with and without previous repeated freezing and thawing. Br J Cancer (1952) 0.75
Observations on purified preparations of the Rous virus; infectivity and structure of the particles. Acta Unio Int Contra Cancrum (1959) 0.75
Nuclear aberrations in cultures of "normal" cells from four animal species. J Comp Pathol (1959) 0.75
The intra-cellular identification of the Rous virus. Ned Tijdschr Geneeskd (1957) 0.75
HAIR-SPRAYS. Lancet (1964) 0.75
AN INTERESTING CASE IN WARD 6. Lancet (1964) 0.75
PREINVASIVE CANCER OF THE CERVIX. Lancet (1964) 0.75
Intra-cellular identification of the Rous virus. Nature (1956) 0.75
DEATHS IN THE COMMUNITY. Lancet (1964) 0.75
Site of virus-like particles in Rous fowl sarcoma cells. Nature (1955) 0.75
Serum lipid studies in euthyroid subjects following the administration of thyroid. Am J Med Sci (1951) 0.75
The use of abdominal supports in patients with angina pectoris as selected by the ballistocardiogram. J Clin Invest (1950) 0.75
Intra-arterial histamine in the treatment of occlusive peripheral arterial disease. Circulation (1952) 0.75